SCHEMBL20909340

SCHEMBL20909340

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3cc4c(cn3)-c3ccccc3-c3ccccc3-c3ccccc3-4)c3ccccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
DHFR P00374 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
PIM1 P11309 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
MET P08581 1/20 0.36
MAOB P27338 1/20 0.35
SIRT2 Q8IXJ6 2/20 0.35
GSTP1 P09211 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20909419 0.94 DHFR (0.44) CYP17A1CYP19A1CYP11B1CYP11B2ADORA2A
SCHEMBL20909343 0.92 DHFR (0.42) CYP17A1CYP19A1CYP11B1CYP11B2ADORA2A
SCHEMBL20909339 0.86 TNF (0.39) KDM4EIDO1TDO2
SCHEMBL20909418 0.82 ENPP1 (0.43) KDM4EHDAC8CYP1A2
SCHEMBL20909432 0.81 CYP11B1 (0.48) CYP17A1CYP19A1CYP11B1CYP11B2ADORA2A
SCHEMBL16303067 0.81 NPC1 (0.49) CYP17A1CYP19A1CYP11B1CYP11B2DHFR
SCHEMBL20909420 0.81 MEN1 (0.40) ESR1ESR2IDO1TDO2
SCHEMBL20909411 0.81 ADORA2A (0.41) CYP17A1CYP19A1CYP11B1CYP11B2ADORA2A
SCHEMBL22127106 0.81 HSD17B1 (0.57) CYP17A1CYP19A1CYP11B1CYP11B2HSD17B1
SCHEMBL29884153 0.81 HSD17B1 (0.57) CYP17A1CYP19A1CYP11B1CYP11B2HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201290-B2 Tetraphenylene anthracene compounds Beijing Summer Sprout Technology Co., Ltd. (CN) 2021-12-14 US disclosed
US-20190115541-A1 TETRAPHENYLENE ANTHRACENE COMPOUNDS Beijing Summer Sprout Technology Co., Ltd. (CN) 2019-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190115541-A1 TETRAPHENYLENE ANTHRACENE COMPOUNDS TRPA1, SLC29A2, XPOT CYP17A1 4192/4885CYP19A1 1366/4885CYP11B1 1655/4885
US-11201290-B2 Tetraphenylene anthracene compounds TRPA1, SLC29A2, XPOT CYP17A1 4192/4885CYP19A1 1366/4885CYP11B1 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.